WIPO

Data

Cmpds

HGNC*

WIPO Title

Organization

Deposition

Downloads

22

MAP4K1 INHIBITORS

Blueprint Medicines

03/05/23

2D 3D TSV

42

HGNC:7660 5295 5294 5293 5182

SEROTONIN 5-HT2A, 5-HT2B, AND 5-HT2C RECEPTOR INVERSE AGONISTS

Northeastern University

03/05/23

2D 3D TSV

10

INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

Mindset Pharma

03/05/23

2D 3D TSV

13

M6PR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES

Lycia Therapeutics

02/02/23

2D 3D TSV

25

TRICYCLIC COMPOUNDS

Recurium Ip Holdings

02/02/23

2D 3D TSV

2

HGNC:2358 2357

NOVEL FATTY ACID MODIFIED UROCORTIN 2 DERIVATIVES AND THE USES THEREOF

Novo Nordisk

02/02/23

2D 3D TSV

25

CDK7 SELECTIVE INHIBITORS AS ANTICANCER AGENTS

Jingrui Biopharma

02/02/23

2D 3D TSV

30

INHIBITORS TARGETING UBIQUITIN SPECIFIC PROTEASE 7 (USP7)

Dana-Farber Cancer Institute

01/31/23

2D 3D TSV

25

ETHER-LINKED ANTIVIRAL COMPOUNDS

Pfizer

01/31/23

2D 3D TSV

22

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRAL RELATED DISEASES

Novartis

01/31/23

2D 3D TSV

10

CORONAVIRUS MAIN PROTEASE INHIBITORS AND METHODS USING SAME

Baylor College of Medicine

01/31/23

2D 3D TSV

46

SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Sanofi

12/30/22

2D 3D TSV

25

AROMATIC BRIDGED RING AMIDE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

F. Hoffmann-La Roche

12/14/22

2D 3D TSV

24

ISOINDOLINONE COMPOUNDS

Monte Rosa Therapeutics

12/14/22

2D 3D TSV

25

TETRAHYDROISOQUINOLINE DERIVATIVES FOR THE TREATMENT OF RED BLOOD DISORDERS AND INFLAMMATORY DISEASES

Sanofi

12/14/22

2D 3D TSV

14

AMIDE DERIVATIVE HAVING ANTIVIRAL ACTIVITY

Shionogi

12/14/22

2D 3D TSV

26

MACROCYCLIC UREA OREXIN RECEPTOR AGONISTS

Merck Sharp &Amp

12/14/22

2D 3D TSV

22

MACROCYCLES CONTAINING A 1,3,4-OXADIAZOLE RING FOR USE AS MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

Vertex Pharmaceuticals

12/14/22

2D 3D TSV

21

INHIBITION OF TYK2 DEPENDENT SIGNALING PATHWAYS

Janssen Pharmaceutica

12/14/22

2D 3D TSV

33

N-SUBSTITUTED 4-(5-PHENYL-1,3,4-OXADIAZOL-2-YL)ANILINE FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

F. Hoffmann-La Roche

12/14/22

2D 3D TSV

24

ARYLOXAZOLO SPIRAL RING DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

F. Hoffmann-La Roche

12/14/22

2D 3D TSV

24

SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

F. Hoffmann-La Roche

12/14/22

2D 3D TSV

26

AROMATIC SPIRO RING AMIDE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

F. Hoffmann-La Roche

12/14/22

2D 3D TSV

19

(AZA)BENZOTHIAZOLYL SUBSTITUTED PYRAZOLE COMPOUNDS

Pfizer

12/14/22

2D 3D TSV

25

MODIFIED ISOINDOLINONES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

Merck Sharp &Amp

12/14/22

2D 3D TSV

31

SARS-COV-2 MPRO INHIBITOR COMPOUNDS

Heptares Therapeutics

10/05/22

2D 3D TSV

32

POLYHETEROCYCLIC GLP-1 R MODULATING COMPOUNDS

Gilead Sciences

10/05/22

2D 3D TSV

110

3-AMINO PYRROLIDINE AND PIPERIDINE MACROCYCLIC OREXIN RECEPTOR AGONISTS

Merck Sharp &Amp

10/05/22

2D 3D TSV

80

CYCLOPENTATHIOPHENE CARBOXAMIDE DERIVATIVES AS PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONISTS

Boehringer Ingelheim International

08/07/22

2D 3D TSV

125

SMALL MOLECULE INHIBITORS OF NF-KB INDUCING KINASE

Janssen Pharmaceutica

08/07/22

2D 3D TSV

42

1-(2-(4-CYCLOPROPYL-1H-1,2,3-TRIAZOL-1-YL)ACETYL)-4-HYDROXYPYRROLIDINE-2-CARBOXA|MIDE DERIVATIVES AS VHL INHIBITORS FOR THE TREATMENT OF ANEMIA

Genentech

08/07/22

2D 3D TSV

49

1-(2-(4-CYCLOPROPYL-1H-1,2,3-TRIAZOL-1-YL)ACETYL)-4-HYDROXY-N-(BENZYL)PYRROLIDIN E-2-CARBOXAMIDE DERIVATIVES AS VHL INHIBITORS FOR THE TREATMENT OF ANEMIA AND CANCER

Genentech

08/07/22

2D 3D TSV

14

N-[2-({4-[3-(ANILINO)-4-OXO-4,5,6,7-TETRAHYDRO-1H-PYRROLO[3,2-C]PYRIDIN-2-YL]PYRIDIN-3-YL)OXY)ETHYL]PROP-2-ENAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER

Bayer Aktiengesellschaft

08/07/22

2D 3D TSV

34

PYRAZOLE DERIVATIVES ASR ET KINASE INHIBITORS

Eli Lilly

08/07/22

2D 3D TSV

47

DIAMINOPYRIMIDINE CARBOXAMIDE INHIBITORS OF HPK1

Merck Sharp &Amp

08/07/22

2D 3D TSV

56

7-AZOLE SUBSTITUTED 2-AMINOQUINAZOLINE INHIBITORS OF HPK1

Merck Sharp &Amp

08/07/22

2D 3D TSV

384

7-PHENYL SUBSTITUTED 2-AMINOQUINAZOLINE INHIBITORS OF HPK1

Merck Sharp &Amp

07/22/22

2D 3D TSV

236

N-LINKED ISOQUINOLINE AMIDES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

Merck Sharp &Amp

07/21/22

2D 3D TSV

61

HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE

Amgen

07/21/22

2D 3D TSV

68

SUBSTITUTED MORPHOLINE COMPOUNDS

Genentech

07/21/22

2D 3D TSV

226

INTERLEUKIN-17 INHIBITORS

Novartis

07/21/22

2D 3D TSV

219

HGNC:6011 3236

SUBSTITUTED 1H-PYRAZOLO[4,3-C]PYRIDINES AND DERIVATIVES AS EGFR INHIBITORS

Boehringer Ingelheim International

07/21/22

2D 3D TSV

80

NOVEL CORONAVIRUS MAIN PROTEASE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF

Sichuan University

06/09/22

2D 3D TSV

19

ANTIVIRAL HETEROARYL KETONE DERIVATIVES

Pfizer

06/09/22

2D 3D TSV

68

HGNC:17582 13013

SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER

The Broad Institute

05/24/22

2D 3D TSV

29

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CRYPTOSPORIDIOSIS

Novartis

05/24/22

2D 3D TSV

229

HGNC:17582 13013

SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER

The Broad Institute

05/24/22

2D 3D TSV

71

PHOSPHOLIPID COMPOUNDS AND USES THEREOF

Gilead Sciences

05/24/22

2D 3D TSV

294

HGNC:26617 10019 8977

TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS

Bristol-Myers Squibb

05/24/22

2D 3D TSV

168

PREPARATION OF OXINDOLE DERIVATIVES AS NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS

Merck Sharp &Amp

05/02/22

2D 3D TSV

141

PREPARATION OF BENZIMIDAZOLONE DERIVATIVES AS NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS

Merck Sharp &Amp

05/02/22

2D 3D TSV

83

HGNC:3827 3826

AMINOIMIDAZOLE FPR2 AGONISTS

Bristol-Myers Squibb

05/02/22

2D 3D TSV

8

DIHYDROOROTATE DEHYDROGENASE INHIBITORS

Janssen Biotech

05/02/22

2D 3D TSV

6

DIHYDROOROTATE DEHYDROGENASE INHIBITORS

Janssen Biotech

05/02/22

2D 3D TSV

25

DIHYDROOROTATE DEHYDROGENASE INHIBITORS

Janssen Biotech

05/02/22

2D 3D TSV

172

CYCLIN-DEPENDENT KINASE 7 (CDK7) NON-COVALENT INHIBITORS

Janssen Pharmaceutica

05/02/22

2D 3D TSV

100

Aminocarbamoyl compounds for the treatment of viral infections

F. Hoffmann-La Roche

03/30/22

2D 3D TSV

178

Sars-cov-2 inhibitors having covalent modifications for treating coronavirus infections

Insilico Medicine Ip

01/27/22

2D 3D TSV

94

Nitrile-containing antiviral compounds

Pfizer

01/13/22

2D 3D TSV

3

Compounds and methods for the treatment of covid-19

Pfizer

01/13/22

2D 3D TSV

44

Compounds and method of treating covid-19

Pfizer

01/13/22

2D 3D TSV

12

Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis

Pfizer

01/31/21

2D 3D TSV

61

Anticoronviral compounds and compositions, their pharmaceutical uses and materials for their synthesis

Pfizer

10/17/20

2D 3D TSV